Prediabetic State (IGT)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Prediabetic State (IGT) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT02969798

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

HYPOTHESIS: Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have distinct pathophysiologic etiologies. Therefore, therapeutic interventions…

United States700 participantsStarted 2014-01-01

Treatment: Dapagliflozin, Saxagliptin

RecruitingPhase 4

NCT06750783

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

This study compares the impact of Xuezhikang and atorvastatin on glucose metabolism to explore the incidence of prediabetes patients developing diabetes after 2…

China398 participantsStarted 2024-12-31

Treatment: Xuezhikang, Atorvastatin

All recent trials (16 shown)

Not Yet RecruitingNot Applicable

NCT07557329

Intestinal Endotoxemia and Beta- Cell Dysfunction in Prediabetics

the goal of this observation study is to learn about association between intestinal endotoxemia and prediabetes lean patients with the aim of prevention of diab…

Egypt120 participantsStarted 2026-05

Treatment: hba1c, lbp, fasting blood sugar, lipogram, fastinf insulin

Active — Not RecruitingPhase 2

NCT05067621

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steat…

The purpose of this study is to understand the role of GLP-1 in the pathogenesis of T2D in youth and explore their potential salutary effects and ability to del…

United States60 participantsStarted 2023-07-17

Treatment: Semaglutide Pen Injector, Placebo

Prediabetic State (IGT)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

All recent trials (16 shown)

Intestinal Endotoxemia and Beta- Cell Dysfunction in Prediabetics

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steat…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

All recent trials (16 shown)

Intestinal Endotoxemia and Beta- Cell Dysfunction in Prediabetics

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steat…

Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes

Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.

Diabetes Prevention Program Outcomes Study

Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes

A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes

Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension a…

Noninvasive Transcutaneous Glucometer Development

To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients

Lantus in Prediabetes